Home / People / Annika Lindemann-Gharany
Portrait ofAnnika Lindemann-Gharany

Annika Lindemann-Gharany, LL.B.

Senior Associate
Rechtsanwältin

CMS Hasche Sigle
Nymphenburger Straße 12
80335 Munich
Germany
Languages German, English

Annika advises companies on trademark and competition law (Unfair Competition Act) matters and on licensing agreements in particular. In these areas, she also represents her clients before court. In addition, Annika has special expertise in design law, copyright law and know-how protection. She also advises clients on the drafting and negotiation of R&D contracts.

Annika joined CMS in 2018.

more less

Memberships & Roles

  • Munich Bar Association
more less

Education

  • 2018: Second state examination in law
  • 2016 - 2018: Trainee lawyer at Karlsruhe Higher Regional Court including placements at a major international law firm in Frankfurt a.M. and an Australian law firm in Sydney, Australia
  • 2016: First state examination in law
  • 2013: Bachelor of Laws, LL.B.
  • 2010 - 2016: Integrated LL.B. and State Examination Program in Law at the University of Mannheim
more less

Feed

11/05/2023
CMS advises Tengelmann Ventures portfolio company Pomélo + Co on the acquisition...
Munich – Pomélo + Co GmbH, which specialises in beauty and personal care, has acquired all the assets of Shyne Labs AG and its range of brands. Through the acquisition, Pomélo + Co is further expanding...
05/04/2023
CMS advises 7-Industries on Series C financing round for space start-up...
Munich – Space start-up Isar Aerospace, developer and manufacturer of launch vehicles for transporting small and medium-sized satellites, has completed a Series C financing round of around EUR 155 million...
24/02/2023
CMS advises shareholders of Factor Eleven on their Exit to Armira
Munich – Factor Eleven, a leading digital marketing software company, announces a strategic collaboration with Armira, an investment holding company focused on family businesses and tech­no­logy. The...
25/07/2022
CMS advises Afinum 9 on joint acquisition with Unigestion of premium food...
Munich – Afinum Neunte Beteili­gungs­gesell­schaft mbH & Co. KG (Afinum 9), together with Unigestion S.A. and the founder of Zeit für Brot, Dirk Steiger, has acquired the Zeit für Brot Group from Afinum...
03/05/2022
CMS advises biotechnology firm Tubulis on EUR 60 million Series B financing...
Munich – Biotech company Tubulis has successfully completed a Series B round of financing worth EUR 60 million. Three new investors, Andera Partners, Evotec SE and Fund+, joined the round. All the existing...
28/01/2022
CMS advises Rigeto and holding company AndCompany on acquisition of ion2s
Munich – A group of investors advised by Rigeto Un­ternehmerkapit­al GmbH has established AndCompany GmbH as a holding company. The aim is to create a network of complementary firms under this umbrella...
17/12/2021
CMS advises Optimapharm on acquisition of SSS International Clinical Research
Munich – Croatian company Optimapharm d.o.o. has acquired SSS International Clinical Research GmbH. Optimapharm is an international contract research organisation (CRO) which primarily conducts clinical...
11/10/2021
CMS advises Canadian financial software provider FreshBooks on acquisition...
Leipzig/Frank­furt am Main – FreshBooks, a leading provider of cloud-based accounting software with customers in more than 160 countries which is headquartered in Toronto (Canada), has acquired FastBill...
24/09/2021
CMS advises Afinum on majority stake in Tisso Naturprodukte
Munich – Afinum Achte Beteili­gungs­gesell­schaft mbH & Co. KG, which is advised by Afinum Management GmbH, has acquired a majority shareholding in Tisso Naturprodukte GmbH, a specialist supplier of therapeutic...
15/09/2021
CMS advises Sirion Biotech shareholders on acquisition by PerkinElmer
Munich – Listed US company PerkinElmer, Inc. has acquired SIRION BIOTECH, a leading global provider of viral vector-based technologies for cell and gene therapies. Sirion has established a strong portfolio...
14/01/2021
CMS advises Afinum on majority stake in SanderStrothmann Group
Munich – Afinum Achte Beteili­gungs­gesell­schaft mbH & Co. KG has indirectly acquired a majority stake in the SanderStrothmann Group, a leading full-service provider of cosmetics, beauty and healthcare...
17/11/2020
CMS advises biotech company Cherry Biolabs on exclusive licence agreement...
Munich – Biotech company Cherry Biolabs, a spin-off from Würzburg University Hospital and an exclusive licensee of Ju­li­us-Max­imili­ans-Uni­ver­sity in Würzburg, has signed an exclusive sub-licence agreement...